Cargando…

Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine

PURPOSE: Nose-to-brain drug delivery is an effective approach for poorly soluble drugs to bypass the blood–brain barrier. A new drug intranasal delivery system, a nanosuspension-based in situ gel, was developed and evaluated to improve the solubility and bioavailability of the drug and to prolong it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yingchong, Liu, Yuling, Xie, Jin, Zheng, Qin, Yue, Pengfei, Chen, Liru, Hu, Pengyi, Yang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767747/ https://www.ncbi.nlm.nih.gov/pubmed/33380794 http://dx.doi.org/10.2147/IJN.S265659

Ejemplares similares

Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
por: Song, Zilin, et al.
Publicado: (2021)

Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder
por: Zhang, Ting, et al.
Publicado: (2022)

In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases
por: Aderibigbe, Blessing Atim
Publicado: (2018)

Nose to brain delivery of Efavirenz nanosuspension for effective neuro AIDS therapy: in-vitro, in-vivo and pharmacokinetic assessment
por: Kakad, Smita, et al.
Publicado: (2021)

Nanocrystals based pulmonary inhalation delivery system: advance and challenge
por: Yue, Pengfei, et al.
Publicado: (2022)

Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to Neuro-AIDS treatment
por: Kakad, Smita P., et al.
Publicado: (2022)

Rufinamide-Loaded Chitosan Nanoparticles in Xyloglucan-Based Thermoresponsive In Situ Gel for Direct Nose to Brain Delivery
por: Dalvi, Avantika, et al.
Publicado: (2021)

Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation
por: Mohanty, Dibyalochan, et al.
Publicado: (2023)

Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review
por: Gao, Jialiang, et al.
Publicado: (2017)

Emerging role of nanosuspensions in drug delivery systems
por: Jacob, Shery, et al.
Publicado: (2020)

Breviscapine Ameliorates Fear Extinction and Anxiety in BALB/cJ Mice
por: Liang, Wei, et al.
Publicado: (2023)

Gellan gum–based in situ gelling ophthalmic nanosuspension of Posaconazole
por: Khare, Purva, et al.
Publicado: (2022)

The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies
por: Dibaei, Maryam, et al.
Publicado: (2019)

Nose-to-Brain Delivery
por: Giunchedi, Paolo, et al.
Publicado: (2020)

Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations
por: Goel, Surya, et al.
Publicado: (2019)

Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery
por: Faizi, Hafsa Shahid, et al.
Publicado: (2022)

Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches
por: Liu, Xiaonan, et al.
Publicado: (2018)

Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery
por: Chiang, Po-Chang, et al.
Publicado: (2009)

Thermoresponsive Gel-loaded Oxcarbazepine Nanosystems for Nose- To-Brain Delivery: Enhanced Antiepileptic Activity in Rats
por: Abou-Taleb, Basant A., et al.
Publicado: (2023)

Breviscapine reduces neuronal injury caused by traumatic brain injury insult: partly associated with suppression of interleukin-6 expression
por: Jiang, Ling, et al.
Publicado: (2017)

Preparation, characterization and pharmacokinetics of cyadox nanosuspension
por: Sattar, Adeel, et al.
Publicado: (2017)

Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
por: Wang, Yonglu, et al.
Publicado: (2011)

Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin
por: Abdelghany, Sharif, et al.
Publicado: (2019)

Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanisms
por: Fu, Weijiang, et al.
Publicado: (2023)

Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy
por: Sun, Linlin, et al.
Publicado: (2023)

Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021)

Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose–sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin
por: Xie, Jin, et al.
Publicado: (2019)

Combination of Dissolving Microneedles with Nanosuspension and Co-Grinding for Transdermal Delivery of Ketoprofen
por: Ramadon, Delly, et al.
Publicado: (2023)

Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery
por: Casula, Luca, et al.
Publicado: (2023)

Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients
por: Wang, Chuan, et al.
Publicado: (2015)

Nanoemulsions for “Nose-to-Brain” Drug Delivery
por: Bonferoni, Maria Cristina, et al.
Publicado: (2019)

Ion-Triggered In Situ Gelling Nanoemulgel as a Platform for Nose-to-Brain Delivery of Small Lipophilic Molecules
por: Nagaraja, Sreeharsha, et al.
Publicado: (2021)

Breviscapine prevents downregulation of renal water and sodium transport proteins in response to unilateral ureteral obstruction
por: Mei, Yang, et al.
Publicado: (2016)

Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity
por: Li, Meng-Jiao, et al.
Publicado: (2022)

Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K/AKT pathway
por: Niu, Pengfei, et al.
Publicado: (2023)

Rapid In Situ MRI Traceable Gel-forming Dual-drug Delivery for Synergistic Therapy of Brain Tumor
por: Lin, Feng-Wei, et al.
Publicado: (2017)

Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
por: Lan, Tian, et al.
Publicado: (2021)

Determination of scutellarin in breviscapine preparations using quantitative proton nuclear magnetic resonance spectroscopy
por: Jiang, Zhenzuo, et al.
Publicado: (2016)

Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity
por: Chiang, Po-Chang, et al.
Publicado: (2014)

Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation
por: Nakarani, M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_eu6qmhbpet7ch13btig4p8m327